Release Date: 17/01/14 17:12 Summary: End of Negotiation Period with Parvulus Suisse SA Price Sensitive: Yes Download Document 39.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%